DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Ablation Devices Global Market - Forecast to 2023" report to their offering.
The ablation device global market is expected to grow at high single digit CAGR to reach $20,995.5 million by 2023.
Ablation is the minimally invasive therapeutic tissue excision procedure used for a wide range of purposes, from cancerous or diseased tissue removal, to the removal of abnormally conducting cardiac tissue in atrial fibrillation and others. The growing adoption of minimally invasive procedures is pushing the researchers to innovate and improvise existing ablation technologies for better patient care.
The major factors influencing growth are an increasing number of ablation procedures, rising incidences of cancer, the emergence of next-generation ablation products and technologies, growing adoption of minimally invasive procedures, and improving reimbursement scenario in established markets. However, reuse and reprocessing of devices in developing countries, healthcare cost-containment measures, stringent regulatory guidelines, and challenges in therapeutic procedures are some of the factors hampering the market.
Companies Mentioned
- Abbott Laboratories
- Access Point Technologies
- Accuray
- Aishen Medical Technologies
- Alcon Research
- Alma
- Alpinion Medical Systems
- Angiodynamics Inc.
- Apama Medical
- Apro Korea
- Aquilant Medical
- Arthrex
- Articure Inc.
- Avinger
- Baylis Medical
- Best Nomos
- Biolitec AG
- Biotronik
- Boston Scientific Corporation
- Bovie Medical
- (80+ Others)
Key Topics Covered:
1 Executive Summary
2 Introduction
3 Market Analysis
4 Ablation Device Global Market, by Technology
5 Ablation Device Global Market, by Application
6 Ablation Device Global Market, by End-Users
7 Regional Market Analysis
8 Company Developments
9 Major Player Profiles
For more information about this report visit http://www.researchandmarkets.com/research/lxvxp7/ablation_devices
